Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,288,480
-
Total 13F shares
-
33,351,676
-
Share change
-
+1,223,954
-
Total reported value
-
$375,205,711
-
Put/Call ratio
-
31%
-
Price per share
-
$11.25
-
Number of holders
-
164
-
Value change
-
+$29,774,145
-
Number of buys
-
78
-
Number of sells
-
64
Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) as of Q2 2025
As of 30 Jun 2025,
Ginkgo Bioworks Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (DNA) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,351,676 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, BAILLIE GIFFORD & CO, BlackRock, Inc., VANGUARD GROUP INC, Erste Asset Management GmbH, Anchorage Capital Group, L.L.C., Legal & General Group Plc, MILLENNIUM MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, and GOLDMAN SACHS GROUP INC.
This page lists
164
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.